Susquehanna International Group, LLP Neogenomics Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $431,480 - $570,906	-32,200 Reduced 38.61%	51,200 $755,000
Q2 2024 Aug 15, 2024	SELL	$13.01 - $15.77 $945,827 - $1.15 Million	-72,700 Reduced 46.57%	83,400 $1.16 Million
Q1 2024 May 07, 2024	SELL	$14.06 - $16.79 $589,114 - $703,501	-41,900 Reduced 21.16%	156,100 $2.45 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $1.57 Million - $2.8 Million	134,900 Added 213.79%	198,000 $3.2 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $561,330 - $824,670	46,200 Added 273.37%	63,100 $776,000
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $125,490 - $176,486	-8,900 Reduced 34.5%	16,900 $271,000
Q1 2023 May 16, 2023	SELL	$9.09 - $19.45 $139,077 - $297,585	-15,300 Reduced 37.23%	25,800 $449,000
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $159,315 - $298,129	-24,700 Reduced 37.54%	41,100 $379,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $238,158 - $391,173	-30,300 Reduced 31.53%	65,800 $567,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.89B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.